Frequently Asked Questions
…the peer review and scoring process. Therefore, no changes can be made after the submission deadline, unless changes or clarification are specifically requested by the abstract review team. Updates and…
CROI 2023 Program
…NEUTRALIZING ANTIBODY POTENCY AND BREADTH Penny Moore, University of the Witwatersrand, Johannesburg, South Africa CASE-BASED DISCUSSION OF CARDIO-METABOLIC COMPLICATIONS OF HIV AND CONSEQUENCES FOR MANAGEMENT Moderators: Georg Behrens, Medizinische Hochschule…
Affiliated and Proximate Activities
…substantive changes to an Affiliated and Proximate Activity application must be reported to CROI. Substantive changes include location, attendee, and major agenda changes. If you are unsure if a change…
Abstract Guidelines and Submission
…prefixes and suffixes. When using scientific names in titles, only the first word begins with a capital letter; the second one remains in lowercase. For example, Dracaena trifasciata. The body…
CROI 2024 Program
…Antibody Protection: Where Do We Go From Here? Yunda Huang, Fred Hutchison Cancer Center (Seattle, WA, USA) Germline Targeting Strategies to Get On the Road Again Rogier W. Sanders, Academic…
CROI Foundation
…Composition of the CROI Foundation BOD The Board of Directors comprises 2 Permanent Directors (cofounders of CROI), 3 Standing Directors (current CROI Chair and 2 Vice Chairs), at least 1…
CROI 2024 Abstract Categories
…(B-cell, T-cell, and innate) to HIV infection and vaccines, and immunomodulatory therapeutic interventions (eg, cytokine interventions, passive antibody treatment). This category includes studies addressing similar areas for SARS-CoV-2 and the…
Scientific Program Committee
…New York, New York, where she researches mechanisms that lentiviruses use to overcome inhibitors in their natural hosts, novel animal models for HIV-1, and antibody-containing plasma from people had recovered…